Drug profile · INN
trimipramine maleate
TRIMIPRAMINE MALEATE
trimipramine maleate (TRIMIPRAMINE MALEATE) is a adrenergic receptor alpha-1 antagonist. Associated with ELITE PHARMACEUTICALS INC /NV/. Route of administration: oral. Current US regulatory status: approved.
Drug details — trimipramine maleate
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 0
- Data quality
- 0.89
Quick answer
trimipramine maleate (TRIMIPRAMINE MALEATE) is a adrenergic receptor alpha-1 antagonist. Associated with ELITE PHARMACEUTICALS INC /NV/. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Adrenergic receptor alpha-1 antagonist
Primary target: Adrenergic receptor alpha-1
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is trimipramine maleate?
trimipramine maleate (TRIMIPRAMINE MALEATE) is a adrenergic receptor alpha-1 antagonist. Associated with ELITE PHARMACEUTICALS INC /NV/. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for trimipramine maleate?
TRIMIPRAMINE MALEATE is a marketed brand name for trimipramine maleate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of trimipramine maleate?
trimipramine maleate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.